Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tissue engineering experts discuss orthopaedics applications

11.04.2005


A future in which laboratory-grown organs and stimulated growth of muscle, bones and nerves could play a major role in treating medical conditions was revealed at a recent Tissue Engineering Symposium at Wake Forest University Baptist Medical Center.

The symposium, sponsored by Wake Forest Baptist and the International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine, was part of the society’s annual conference. Tissue engineering experts from Wake Forest Baptist, Children’s Hospital of Pittsburgh, Carnegie Mellon University, the University of Texas at Austin, as well as Italy and Japan, discussed their latest work.

Tissue engineering, a term that was coined in 1986, describes the science of replacing, repairing or regenerating organs or tissue. The term is often used interchangeably with regenerative medicine.



In the field of orthopaedics, researchers described using growth factors to regenerate bone, using new technologies to enhance the healing of ligaments, efforts to produce tissue-engineered cartilage, and the possibility of use stem cells derived from muscle to improve bone healing. These advances could provide better treatments for sports injuries, cleft palate and osteoporosis, the researchers said.

"The potential in orthopaedics is not only to manage devastating congenital or traumatic problems but also to prevent or slow degenerative processes in order to maintain the activity and function of our aging population," said Gary G. Poehling, M.D., professor and chairman of othopaedics at Wake Forest Baptist.

Anthony Atala M.D., director of the Wake Forest Institute of Regenerative Medicine, said that laboratory-grown organs may one day help alleviate the shortage of donated organs for transplantation. Atala has developed bioengineered urethras, the tube through which urine is excreted from the bladder, that have been successfully implanted in humans. He has also created blood vessels, muscle, bladders, wombs, and vaginas that have been successfully tested in large animals and are close to being ready to test in humans.

Atala’s team is working to use patients’ own cells to grow more than 20 different tissue types. They harvest cells from humans and apply growth factors, to cause the cells to multiply outside the body. It can take years to develop and perfect these growth factors, which cause a group of cells about one centimeter in size to multiply to fill a football field in about 60 days. The cells are "seeded" on a model, or scaffold, where they continue to grow. The next step is implanting the model in the body, where the scaffold eventually degrades as the new organ or tissue integrates with the body.

In addition to engineering tissues and organs, Atala and his team are also working to identify new sources of stem cells. Because these cells are unspecialized, they can acquire the structure and features of other cell types, and some researchers believe they could be used to replace defective insulin-producing cells in the pancreas, as well as to treat Alzheimer’s, liver, heart, muscular and vascular diseases.

Robert Nerem, Ph.D., director of the Parker H. Petit Institute for Bioengineering and Bioscience at the Georgia Institute of Technology predicted that one day tissue engineering and regenerative medicine will result in a revolution in the medical implant industry.

But Nerem and others who work in this emerging field said that while the area is full of promise, there are still many challenges to face before new therapies will be widely available.

"These technologies are expensive and for some of them, distribution is a challenge," said Atala.

Karen Richardson | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>